全球非鴉片類止痛貼市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

非鴉片類止痛貼市場預計將從 2025 年的 10.7 億美元成長到 2034 年的 19.1 億美元，2026 年至 2034 年的複合年成長率為 6.69%。

隨著醫療機構和患者尋求更安全的鴉片類止痛藥替代方案，全球非鴉片類止痛貼市場正在快速成長。非鴉片類止痛貼片透過皮膚輸送藥物，緩解局部疼痛，且無鴉片類藥物依賴的風險。這些貼片擴大用於治療肌肉疼痛、關節炎和術後不適等疾病。

推動市場成長的關鍵因素之一是人們對鴉片類藥物成癮及其相關健康併發症日益成長的擔憂。各國政府和醫療機構正積極推廣非鴉片類治療方法，以減少對傳統止痛藥的依賴。此外，經皮給藥技術的進步也提高了止痛貼片的有效性和便利性。

由於藥物配方和貼片技術的不斷創新，非鴉片類鎮痛貼片市場預計未來將持續成長。研究人員正在探索新的活性成分和改進的給藥機制，以提供更持久的鎮痛效果。隨著醫療保健產業不斷致力於開發更安全的疼痛管理方案，對非鴉片類鎮痛貼片的需求可能會顯著增加。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球非鴉片類止痛貼市場：依貼片類型分類

• 市場分析、洞察與預測
• Lidocaine貼劑
• 雙氯芬酸鈉貼劑
• 水楊酸甲酯貼片
• 辣椒素貼片
• 酮洛芬貼劑
• 其他（草本、薄荷醇等）

第5章 全球非鴉片類止痛貼市場：依通路分類

• 市場分析、洞察與預測
• 零售藥房
• 醫院藥房
• 網路藥房
• 其他（超級市場/大賣場、DTC）

第6章 全球非鴉片類止痛貼市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第7章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第8章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Acorda TherapeuticsInc
  • Teva Pharmaceutical Industries Ltd
  • GSK Plc
  • Endo International Plc
  • Hisamitsu Pharmaceutical Co.Inc
  • IBSA（Institut Biochimique SA）
  • Alkermes Plc
  • Teikoku Seiyaku Co.Ltd
  • Mylan NV

The Non-Opioid Pain Patches Market size is expected to reach USD 1.91 Billion in 2034 from USD 1.07 Billion (2025) growing at a CAGR of 6.69% during 2026-2034.

The Global Non-Opioid Pain Patches Market is growing rapidly as healthcare providers and patients seek safer alternatives to opioid-based pain medications. Non-opioid pain patches deliver medication through the skin to relieve localized pain without the risk of opioid dependency. These patches are increasingly used to manage conditions such as muscle pain, arthritis, and post-surgical discomfort.

One of the major drivers of the market is the rising concern over opioid addiction and related health complications. Governments and healthcare organizations are promoting non-opioid treatment options to reduce reliance on traditional painkillers. In addition, advances in transdermal drug delivery technology have improved the effectiveness and convenience of pain relief patches.

In the future, the non-opioid pain patches market is expected to expand with continued innovation in drug formulations and patch technologies. Researchers are exploring new active ingredients and enhanced delivery mechanisms that provide longer-lasting pain relief. As the healthcare industry continues to focus on safer pain management solutions, the demand for non-opioid pain patches is likely to increase significantly.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Patch Type

• Lidocaine Patches
• Diclofenac Patches
• Methyl Salicylate Patches
• Capsaicin Patches
• Ketoprofen Patches
• Others (Herbal, Menthol, etc.)

By Distribution Channel

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies
• Others (Supermarkets/Hypermarkets, DTC)

COMPANIES PROFILED

• Acorda Therapeutics, Inc, Teva Pharmaceutical Industries Ltd, GSK plc, Endo International plc, Hisamitsu Pharmaceutical Co, Inc, IBSA Institut Biochimique SA, Alkermes plc, Teikoku Seiyaku Co, Ltd, Mylan NV
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL NON-OPIOID PAIN PATCHES MARKET: BY PATCH TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Patch Type
• 4.2. Lidocaine Patches Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Diclofenac Patches Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Methyl Salicylate Patches Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Capsaicin Patches Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Ketoprofen Patches Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Others (Herbal, Menthol, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NON-OPIOID PAIN PATCHES MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Distribution Channel
• 5.2. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others (Supermarkets/Hypermarkets, DTC) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NON-OPIOID PAIN PATCHES MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Patch Type
  • 6.2.2 By Distribution Channel
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Patch Type
  • 6.3.2 By Distribution Channel
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Patch Type
  • 6.4.2 By Distribution Channel
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Patch Type
  • 6.5.2 By Distribution Channel
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Patch Type
  • 6.6.2 By Distribution Channel
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL NON-OPIOID PAIN PATCHES INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Acorda TherapeuticsInc
  • 8.2.2 Teva Pharmaceutical Industries Ltd
  • 8.2.3 GSK Plc
  • 8.2.4 Endo International Plc
  • 8.2.5 Hisamitsu Pharmaceutical Co.Inc
  • 8.2.6 IBSA (Institut Biochimique SA)
  • 8.2.7 Alkermes Plc
  • 8.2.8 Teikoku Seiyaku Co.Ltd
  • 8.2.9 Mylan N.V